Idioma:

Who is more likely to respond to dual treatment with pegylated-interferon and ribavirin for chronic hepatitis C? A gender-oriented analysis

Di Marco, V. ; Covolo, L. ; Calvaruso, V. ; Levrero, M. ; Puoti, M. ; Suter, F. ; Gaeta, G. B. ; Ferrari, C. ; Raimondo, G. ; Fattovich, G. ; Santantonio, T. ; Alberti, A. ; Bruno, R. ; Mussini, C. ; Mondelli, M. ; Donato, F. ; Craxì, A.

Journal of viral hepatitis, 2013-11, Vol.20 (11), p.790-800 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por

Enviar para

Título:
Who is more likely to respond to dual treatment with pegylated-interferon and ribavirin for chronic hepatitis C? A gender-oriented analysis
Autor: Di Marco, V. ; Covolo, L. ; Calvaruso, V. ; Levrero, M. ; Puoti, M. ; Suter, F. ; Gaeta, G. B. ; Ferrari, C. ; Raimondo, G. ; Fattovich, G. ; Santantonio, T. ; Alberti, A. ; Bruno, R. ; Mussini, C. ; Mondelli, M. ; Donato, F. ; Craxì, A.
Assuntos: Adult ; Age ; Aged ; chronic hepatitis C ; Cohort Studies ; Drug Therapy, Combination - methods ; Female ; gender ; HCV-RNA levels ; Hepacivirus - isolation & purification ; Hepatitis C virus ; Hepatitis C, Chronic - drug therapy ; Humans ; IL28B polymorphisms ; Interferons - therapeutic use ; Male ; Middle Aged ; peg-interferon and ribavirin ; Prospective Studies ; Ribavirin - therapeutic use ; Sex Factors ; sustained virologic response ; Treatment Outcome ; Viral Load
É parte de: Journal of viral hepatitis, 2013-11, Vol.20 (11), p.790-800
Notas: istex:124DA9083FC9332589B3134412A58FEDFDDFE701
ark:/67375/WNG-1WWHXXNX-V
ArticleID:JVH12106
Agenzia Italiana del Farmaco (Italian Medicines Agency)
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
Descrição: Summary We assessed, in real‐life practice, viral, demographic, genetic and metabolic factors influencing the sustained virologic response (SVR), with a gender‐oriented analysis, in patients with chronic hepatitis C virus (HCV) treated with pegylated interferon and ribavirin. Six hundred and seventy naïve patients were treated with dual therapy and evaluated by gender and HCV genotype. Associations between baseline variables and SVR were assessed by multivariate logistic regression analysis. Among 362 genotype 1 patients, SVR was achieved in 158 patients (44%), and SVR was independently associated with age less than 50 years (OR 2.12; 95% CI 1.09–4.30; P = 0.039) and C/C genotype rs12979860 SNP (OR 2.83; 1.19–6.74; P = 0.002) in 163 females, while absence of visceral obesity (OR 2.491; 1.131–5.487; P = 0.023), HCV‐RNA lower than 400 000 IU/mL (OR 2.66; 1.273–5.558; P = 0.009) and C/C genotype rs12979860 SNP (OR 4.969; 2.401–10.283; P < 0.001) were independently associated with SVR in 199 males. Combining favourable baseline variables, the probability of obtaining SVR ranged from 27.6% to 84.2% in females, and from 14.3% to 85.7% in males. The rate of SVR was 81.1% in 175 genotype 2 patients, and 69% in 100 genotype 3 patients. Rapid virologic response was the only valid predictor of SVR regardless of other features. In conclusions, in the setting of HCV genotype 1, chronic hepatitis, combining rapid virologic response and predictive factors, which are different for females and males, allows clinicians to single out a group of patients whose likelihood of SVR exceeds 80%. For these patients, triple therapy with first‐generation protease inhibitors may be unwarranted.
Editor: England: Blackwell Publishing Ltd
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Anterior Resultado 10 Avançar Ir para próxima página

Realização: Logos de Redes Sociais:

Who is more likely to respond to dual treatment with pegylated-interferon and ribavirin for chronic hepatitis C? A gender-oriented analysis

Di Marco, V. ; Covolo, L. ; Calvaruso, V. ; Levrero, M. ; Puoti, M. ; Suter, F. ; Gaeta, G. B. ; Ferrari, C. ; Raimondo, G. ; Fattovich, G. ; Santantonio, T. ; Alberti, A. ; Bruno, R. ; Mussini, C. ; Mondelli, M. ; Donato, F. ; Craxì, A.

England: Blackwell Publishing Ltd

Buscando em bases de dados remotas. Favor aguardar.